[Not Published Yet] Randomized Trial: Improved Outcomes with Myeloablative Therapy Compared to Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Myeloablative Therapy Prevails in AML Transplant Study – MedPage Today (free registration required)

Original Study Abstract: 11 – Long-Term Follow up of BMT CTN 0901, a Randomized Phase III Trial Comparing Myeloablative (MAC) to Reduced Intensity Conditioning (RIC) Prior to Hematopoietic Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS) (MAvRIC Trial) – Presented at Transplantation and Cellular Therapy Meetings (free)

Original Report: Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes – Journal of Clinical Oncology (free)